HYPOPHOSPHATEMIA AND HEMOLYTIC-ANEMIA ASSOCIATED WITH DIABETES-MELLITUS AND HEPATIC LIPIDOSIS IN CATS

被引:47
作者
ADAMS, LG
HARDY, RM
WEISS, DJ
BARTGES, JW
机构
[1] UNIV MINNESOTA,COLL VET MED,DEPT SMALL ANIM CLIN SCI,ST PAUL,MN 55108
[2] UNIV MINNESOTA,COLL VET MED,DEPT VET PATHOBIOL,ST PAUL,MN 55108
关键词
D O I
10.1111/j.1939-1676.1993.tb01018.x
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Hypophosphatemia associated with hemolytic anemia was diagnosed in five cats with diabetes mellitus and in one cat with idiopathic hepatic lipidosis. The hematocrit began decreasing within 24 to 48 hours after documented hypophosphatemia in each case. The anemia resolved in all five surviving cats. Because of the temporal relationship and lack of other detectable causes, hemolytic anemia was presumed to be caused by hypophosphatemia. There were increased Heinz bodies in three of six hypophosphate‐mic cats during episodes of hemolysis. Intravenous potassium phosphate administration corrected the hypophosphatemia in four of five cats. The effective dosages of intravenous phosphate ranged from 0.011 to 0.017 mmol of phosphate/kg/h for 6 to 12 hours. Hypocalcemia (5.4 to 8.7 mg/dL) occurred in four of five cats treated with intravenous phosphate; however, only one cat developed clinical signs attributable to hypocalcemia. Based on this retrospective study, we recommend monitoring serum phosphorus concentration every 6 to 12 hours in cats likely to become hypophosphatemic. Treatment of hypophosphatemia in cats is warranted because of the apparent increased susceptibility of cats to hypophosphatemia‐induced hemolysis. Cats with severe hypophosphatemia (≤1.5 mg/dL) should be given oral or parenteral phosphate if contraindications do not exist. (Journal of Veterinary Internal Medicine 1993; 7:266–271. Copyright © 1993 by the American College of Veterinary Internal Medicine.) Copyright © 1993, Wiley Blackwell. All rights reserved
引用
收藏
页码:266 / 271
页数:6
相关论文
共 37 条
[1]  
Willard MD, Zerbe CA, Schall WD, Et al., Severe hypophosphatemia associated with diabetes mellitus in six dogs and one cat, J Am Vet Med Assoc, 190, pp. 1007-1010, (1987)
[2]  
Forrester SD, Moreland KJ., Hypophosphatemia: Causes and clinical consequences, J Vet Intern Med, 3, pp. 149-159, (1989)
[3]  
Stoff JS., Phosphate homeostasis and hypophosphatemia, Am J Med, 72, pp. 489-495, (1982)
[4]  
Juan D., Mohamed AE., Hypophosphatemia in hospitalized patients, J Am Med Assoc, 242, pp. 163-164, (1979)
[5]  
Kurokawa K., Levine BS, Lee DB, Et al., Physiology of phosphorus metabolism and pathophysiology of hypophosphatemia and hyperphosphatemia, Fluid, Electrolyte, and Acid‐Base Disorders, pp. 625-659, (1985)
[6]  
Knochel JP., The pathophysiology and clinical characteristics of severe hypophosphatemia, Arch Intern Med, 137, pp. 203-220, (1977)
[7]  
Ladefoged K., Jarnum S., Metabolic complications to total parenteral nutrition, Acta Anaesthesiol Scand, 29, pp. 89-94, (1985)
[8]  
Solomon SM, Kirby DF., The refeeding syndrome: A review, J Parenter Enteral Nutr, 14, pp. 90-97, (1990)
[9]  
Jacob HS, Amsden T., Acute hemolytic anemia with rigid cells in hypophosphatemia, N Engl J Med, 285, pp. 1446-1450, (1971)
[10]  
Klock JC, Williams HE, Mentzer WC, Hemolytic anemia and somatic cell dysfunction in severe hypophosphatemia, Arch Intern Med, 134, pp. 360-364, (1974)